Document is current
Any future updates will be listed below
-
Authors
Daehn, Ilse S. https://orcid.org/0000-0001-9915-5376
Duffield, Jeremy S. https://orcid.org/0000-0002-3838-0630
- License Information
-
More Information
Article History
Accepted: 28 May 2021
First Online: 14 July 2021
Competing interests
: J.S.D. is a former employee of Vertex Pharmaceuticals, which is developing VX-147 for the treatment of APOL1-mediated kidney disease, holds Vertex stock and holds patents for the invention and use of Lademirsen for the treatment of kidney diseases including Alport syndrome. I.S.D. declares no competing interests.
